No Detail Found!

Montelukast - An Effective and Simple Therapeutic Option in Bronchiolitis

Author(s)
MUHAMMAD NADEEM HAMEED Department of Pediatrics Shalamar Medical & Dental College, Shalimar Link Road Lahore, Pakistan
SABA ABDUL SATTAR Department of Pediatrics Shalamar Medical & Dental College, Shalimar Link Road Lahore, Pakistan
WAQAR HUSSAIN Department of Pediatrics Shalamar Medical & Dental College, Shalimar Link Road Lahore, Pakistan
Abstract
Introduction: Bronchiolitis is characterized by inflammation of bronchioles mostly affecting infants. Despite being the commonest lower respiratory infection globally, there is no single .effective, reliable, easy-to-administer therapeutic remedy available for treatment of bronchiolitis. Montelukast - an anti leukotriene agent has been used in modifying the disease severity and duration of illness with variable results. Objective: We evaluated the role of montelukast in modifying the disease severity and duration of illness among hospitalized children with first episode of bronchiolitis. Study Design: Analytical clinical trial. Place of Study: Departments of Paediatrics, Shalamar Medical & Dental College, Lahore. Duration of study: 1st September 2013 till 31stJanuary 2014  Materials & Methods: Sixty children of both genders, between 3 and 24 months of age, admitted with first episode of bronchiolitis were included. Each case was given standard treatment with nebulised salbutamol along with oxygen and other supportive measures as required. Patients were randomized within 12 hours of admission to receive either daily dose of montelukast or no additional drug; dividing the study population into “Interventional” and “Non-Interventional” groups. Daily clinical severity score along with duration of hospital stay was recorded in both the groups being medically fit for discharge. Results: Interventional group had significantly lesser “Clinical Severity Score” and “hospital stay before discharge” when compared with Noninterventional group (p-values 0.003 and <0.001 respectively) Conclusion: Montelukast is an effective therapeutic option for reducing clinical severity of disease and hospital stay in children with first episode of bronchiolitis. 
Publication Details
Page(s) 229-234
DOI DOI not available
Published Journal: Pakistan Paediatric Journal, Volume: 38, Issue: 4, Year: 2014

Request the full text from PASTIC

Keywords
bronchiolitis, Medically fit for discharge, Clinical Severity Score, Montelukast
0

Citations

0

Downloads

74

Views